Navigation Links
Today's Research: Inovio Pharma, Sequenom, Peregrine Pharma, Onyx Pharma, and Optimer Pharma

LONDON, June 20, 2013 /PRNewswire/ --

The U.S. Supreme Court's decision last week on human gene patents is likely to have a major impact on the biotechnology industry, especially on smaller companies. The Supreme Court last week ruled that a naturally occurring DNA segment is a product of nature, and not patent-eligible just because it has been isolated. On Wednesday, June 19, 2013, shares in biotechnology companies ended mostly lower, tracking losses in the broader market, which fell sharply after market participants digested comments from Federal Reserve Chairman Ben Bernanke. The major movers in the sector included Inovio Pharmaceuticals Inc. (AMEX: INO), Sequenom Inc. (NASDAQ: SQNM), Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM), Onyx Pharmaceuticals Inc. (NASDAQ: ONXX), and Optimer Pharmaceuticals Inc. (NASDAQ: OPTR). have completed their technical analysis on INO, SQNM, PPHM, ONXX, and OPTR and these free reports are accessible by registering at  

Shares in Inovio Pharmaceuticals Inc. moved lower on Wednesday, reversing some of their gains from earlier in the week. The company's shares traded between $0.66 and $0.70 before finishing the day 0.57% lower at $0.69. A total of 758,372 shares were traded which is below the daily average volume of 1.36 million. Shares of INO are now up more than 3.70% for this week. Sign up for free technical research on INO at:

Sequenom Inc.'s stock moved higher yesterday even as the broader market struggled. The company's shares traded between $4.18 and $4.37 before finishing the day 0.72% higher at $4.22. A total of 1.69 million shares were exchanged which is below the daily average volume of 2.53 million. However, despite the gains, Sequenom's shares are down 3.87% so far this week. Be sure to read our latest technical research on SQNM by registering at:

Shares in Peregrine Pharmaceuticals fell on Wednesday, tracking losses in the broader market. The company's shares hit an intraday low of $1.46 before finishing the day 1.33% lower at $1.48. A total of 1.04 million shares were traded which is below the daily average volume of 3.19 million. Peregrine's shares have recently slipped below their 50-day and 200-day moving averages. Sign up and read the complimentary report on PPHM at:

Onyx Pharmaceuticals Inc.'s stock fell sharply on Wednesday, extending its losses for the week. The company's shares ended the day 3.67% lower at $85.54 after trading between $85.45 and $88.80. A total of 960,263 shares were traded which is below the daily average volume of 1.16 million. Onyx's shares have now fallen more than 5% in the last three trading sessions. The stock is currently trading below its 50-day moving average. The free report on ONXX can be downloaded by signing up now at:

Shares in Optimer Pharmaceuticals Inc. fell yesterday, tracking losses in the broader market. The company's shares ended the day 0.76% lower at $14.33 after trading between $14.25 and $14.61. A total of 459,088 shares were traded which is below the daily average volume of 1.12 million. Optimer's shares have now fallen over 1.50% so far this week. In the last three months, the stock has gained over 17.60%, thus outperforming the S&P 500. Shares of the company are currently trading slightly below their 50-day moving average. A free report on OPTR can be accessed by registering at:



  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at
  5. For any urgent concerns or inquiries, please contact us at
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to for consideration.


Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.


Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.


Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

SOURCE AAA Research Reports
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medical Devices Research: Country Reports on Market Profile, Competitive Environment and more at
2. New Research: Nationwide Report Shows Prescribed Drugs Not Detected in More Than One-Third of Pain Patient Samples
3. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
4. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
5. Inovio Pharmaceuticals to Present at SPI 2012
6. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
7. Inovio Pharmaceuticals to Present at JMP Investor Conference
8. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
9. Inovio Pharmaceuticals Inc. to Webcast, Live, at on August 2nd
10. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at
11. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
Post Your Comments:
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., ... analytics, today announced that it has been ranked #1 by ... Black Book™ Rankings 2017 User Survey. ZirMed was recognized ... for large hospitals and medical centers over 200 beds and ... Book,s healthcare technology user survey history. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... While it’s often important to take certain medications during the night, finding them ... a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX to provide ... need to turn on a light when taking medication during the night, allowing the ...
(Date:10/13/2017)... ... ... PurhealthRX , a leading Health and Nutrition Company, is announcing the ... spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the amount ... into liquid products, while reducing costs to end users. , The team of researchers ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton ... staged a mock evacuation of the facility as part of a disaster drill on ... Echo Hose EMS and Shelton City Emergency Manager, as well as the Connecticut ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
Breaking Medicine News(10 mins):